Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Vaccine makers fall
Vaccines makers close lower on reports RFK Jr may head HHS
Shares of vaccine makers closed lower Thursday amid reports that President-elect Donald Trump was set to nominate vaccine critic Robert F. Kennedy Jr. as secretary of the U.S. Department of Health and Human Services,
Vaccine makers fall after Trump nominates RFK to head HHS
BioNTech (BNTX), Pfizer (PFE), Novavax (NVAX), Vaxcyte (PCVX) and GSK (GSK) moved lower at the end of the trading day following reports that President-elect Donald Trump Donald Trump would nominate noted vaccine skeptic Robert F.
Trump expected to nominate RFK Jr. for HHS secretary, 3 sources say
President-elect Donald Trump is expected to nominate Robert F. Kennedy Jr. to lead the Department of Health and Human Services, according to three sources familiar with the selection. Kennedy has a long record of criticizing vaccines,
Global Measles Cases Up 20% In A Year
Global measles cases jumped in 2023 due to 'inadequate' vaccine coverage
Measles cases rose 20% last year, driven by a lack of vaccine coverage in the world's poorest countries and those riddled with conflict, the World Health Organization and the U.S. Centers for Disease Control and Prevention (CDC) said on Thursday.
Measles cases up 20% globally as vaccinations decline
Measles is making a comeback, with cases up more than 20% across the globe to more than 10.3 million over the last year, the World Health Organization and the U,S, Centers for Disease Control and Prev
Global Measles Cases Up 20% In A Year, With Poor Vaccination To Blame
Young children are particularly vulnerable to the disease, which killed an estimated 107,500 people in 2023, most of whom were under 5.
3h
Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics
Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.
FiercePharma
1d
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
bnnbloomberg
17h
Merck KGaA Beats Estimates on Boost From Life Science Unit
At the core of this is a recovery for its life science unit, which dipped last year as its boom from components for Covid ...
13d
Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
Merck's Q3 revenue rises, led by Keytruda's strong 17% YoY growth. Gardasil demand challenges in China impact sales, with ...
BioSpace
7d
Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, but RSV Shot Disappoints
While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...
Medpage Today on MSN
3d
Real-World Data on the RSV Vaccine for Older Adults
Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...
13d
Merck & Co.: Hold Rating Amid Declining Gardasil Shipments and Inventory Challenges
In a report released yesterday, Mohit Bansal from Wells Fargo assigned a Hold rating on Merck & Company (MRK – Research Report), ...
7d
Merck: An Undervalued Dividend Machine
Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...
1d
Russia says African, ex-Soviet countries interested in its mpox vaccine
Several African and ex-Soviet countries have expressed interest in buying Russia's vaccine against smallpox and mpox viruses, ...
13d
Merck & Company: Navigating One-Time Charges and Uncertainty in Gardasil Sales Amidst Strategic Shifts
Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Merck & Company (MRK – Research Report), reducing the price ...
Pharmabiz
1d
Merck to present new data from Gardasil 9 studies reinforcing the importance of gender-neutral HPV vaccination in adults up to age 45 at IPVC 2024
Rahway, New Jersey Wednesday, November 13, 2024, 13:00 Hrs [IST] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback